Cap Patients w/ hepatic or severe renal dysfunction.
Tab Gallbladder disease, hypersensitivity to fenofibrate including severe skin rashes, active liver disease, primary biliary cirrhosis, unexplained persistent liver function abnormality, nursing mothers, severe renal dysfunction.